Results 71 to 80 of about 524 (148)

AOP report: Development of an adverse outcome pathway for deposition of energy leading to abnormal vascular remodeling

open access: yesEnvironmental and Molecular Mutagenesis, Volume 65, Issue S3, Page 4-30, October 2024.
Abstract Cardiovascular diseases (CVDs) are complex, encompassing many types of heart pathophysiologies and associated etiologies. Radiotherapy studies have shown that fractionated radiation exposure at high doses (3–17 Gy) to the heart increases the incidence of CVD.
Tatiana Kozbenko   +14 more
wiley   +1 more source

Biological biomarkers of oral cancer

open access: yesPeriodontology 2000, Volume 96, Issue 1, Page 250-280, October 2024.
Abstract The oral squamous cell carcinoma (OSCC) 5 year survival rate of 41% has marginally improved in the last few years, with less than a 1% improvement per year from 2005 to 2017, with higher survival rates when detected at early stages. Based on histopathological grading of oral dysplasia, it is estimated that severe dysplasia has a malignant ...
Allan Radaic   +9 more
wiley   +1 more source

Multicentre study and systematic review: Allopurinol exposure during pregnancy

open access: yesAlimentary Pharmacology &Therapeutics, Volume 60, Issue 4, Page 503-518, August 2024.
Despite being the largest study to date, evidence regarding the risk of adverse pregnancy outcomes after allopurinol exposure remains limited. Interestingly, both our multicentre study and systematic review sub‐analysis in IBD‐pregnancies revealed a relatively low risk of congenital malformations after foetal exposure to a low dose of allopurinol in ...
Femke Crouwel   +14 more
wiley   +1 more source

Effect of allopurinol and oxypurinol treatment on apoptosis in an experimental testicular torsion model

open access: yes
BACKGROUND: The aim of this study was to investigate whether allopurinol and oxypurinol treatment could mitigate oxidative stress and germ cell apoptosis in testicular ischemia-reper fusion (IR) injury.
KART, Yeliz   +4 more
core   +1 more source

How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based dose

open access: yesArthritis Research & Therapy, 2018
Objective Allopurinol dosing has frequently been limited based on creatinine clearance (CrCL), resulting in failure to achieve target serum urate (SU).
Lisa K. Stamp   +7 more
doaj   +1 more source

Research on the effects of intestinal FXR agonists and antibiotics on the regulation of red kidney bean polysaccharides in the liver metabolism in mice with type 2 diabetes

open access: yeseFood, Volume 5, Issue 3, June 2024.
In a mouse model of type 2 diabetes, we used antibiotics and the intestinal fxr agonist Fexaramine to interfere with the intestinal flora and activate the intestinal fxr to investigate whether red kidney bean polysaccharides (RKB) could still have a protective effect on the hepatic function of diabetic mice under the premise that the intestinal flora ...
Yunhui Zhang   +9 more
wiley   +1 more source

Treatment with allopurinol and oxypurinol promotes osteoblast differentiation and increases bone formation

open access: yes, 2014
Allopurinol and, and its active metabolite, oxypurinol are widely used in the treatment of gout and hyperuricemia. They act by inhibiting xanthine oxidase an enzyme in the purine degradation pathway that converts xanthine to uric acid.
Arnett, Timothy   +3 more
core   +1 more source

Oxypurinol administration fails to prevent free radical-mediated lipid peroxidation during loaded breathing

open access: yes, 1999
The purpose of the present study was to determine whether it is possible to alter the development of fatigue and ablate free radical-mediated lipid peroxidation of the diaphragm during loaded breathing by administering oxypurinol, a xanthine oxidase ...
A. DiMarco   +4 more
core   +1 more source

Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion.

open access: yes, 1987
To explore the role of oxygen free radicals produced by the xanthine oxidase pathway on infarct size and left ventricular function, the effect of oxypurinol, an active metabolite of allopurinol and a potent noncompetitive inhibitor of xanthine oxidase ...
D W Puett   +6 more
core   +1 more source

Prevention of reperfusion injury in ischemic-reperfused hearts by oxypurinol and allopurinol

open access: yesTransplant International, 1989
We investigated the effects of the xanthine oxidase inhibitor allopurinol and its metabolite oxypurinol on isolated rabbit hearts. To assess the potential role of these drugs in preventing reperfusion injury, hearts were perfused using Langendorff techniques, held globally ischemic for 3 h at 15 degrees C, and then reperfused.
L, LoBalsamo   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy